Ad is loading...
ADPT
Price
$5.08
Change
-$0.50 (-8.96%)
Updated
Nov 15 closing price
93 days until earnings call
CSLLY
Price
$88.26
Change
-$3.45 (-3.76%)
Updated
Nov 15 closing price
Ad is loading...

ADPT vs CSLLY

Header iconADPT vs CSLLY Comparison
Open Charts ADPT vs CSLLYBanner chart's image
Adaptive Biotechnologies
Price$5.08
Change-$0.50 (-8.96%)
Volume$1.46M
CapitalizationN/A
CSL
Price$88.26
Change-$3.45 (-3.76%)
Volume$130.37K
CapitalizationN/A
ADPT vs CSLLY Comparison Chart
Loading...
ADPT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CSLLY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ADPT vs. CSLLY commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADPT is a StrongSell and CSLLY is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (ADPT: $5.08 vs. CSLLY: $88.26)
Brand notoriety: ADPT: Notable vs. CSLLY: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADPT: 136% vs. CSLLY: 512%
Market capitalization -- ADPT: $749.7M vs. CSLLY: $87.08B
ADPT [@Biotechnology] is valued at $749.7M. CSLLY’s [@Biotechnology] market capitalization is $87.08B. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADPT’s FA Score shows that 0 FA rating(s) are green whileCSLLY’s FA Score has 1 green FA rating(s).

  • ADPT’s FA Score: 0 green, 5 red.
  • CSLLY’s FA Score: 1 green, 4 red.
According to our system of comparison, ADPT is a better buy in the long-term than CSLLY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADPT’s TA Score shows that 3 TA indicator(s) are bullish while CSLLY’s TA Score has 4 bullish TA indicator(s).

  • ADPT’s TA Score: 3 bullish, 7 bearish.
  • CSLLY’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CSLLY is a better buy in the short-term than ADPT.

Price Growth

ADPT (@Biotechnology) experienced а -12.71% price change this week, while CSLLY (@Biotechnology) price change was -5.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

ADPT is expected to report earnings on Feb 18, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CSLLY($87.1B) has a higher market cap than ADPT($750M). ADPT YTD gains are higher at: 3.673 vs. CSLLY (-7.932). CSLLY has higher annual earnings (EBITDA): 4.73B vs. ADPT (-179.85M). CSLLY has more cash in the bank: 885M vs. ADPT (292M). ADPT has less debt than CSLLY: ADPT (94.2M) vs CSLLY (12.2B). CSLLY has higher revenues than ADPT: CSLLY (14.7B) vs ADPT (169M).
ADPTCSLLYADPT / CSLLY
Capitalization750M87.1B1%
EBITDA-179.85M4.73B-4%
Gain YTD3.673-7.932-46%
P/E RatioN/A32.39-
Revenue169M14.7B1%
Total Cash292M885M33%
Total Debt94.2M12.2B1%
FUNDAMENTALS RATINGS
CSLLY: Fundamental Ratings
CSLLY
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
PROFIT vs RISK RATING
1..100
80
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
75
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADPTCSLLY
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
58%
Momentum
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
60%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
71%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
60%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
57%
Advances
ODDS (%)
Bullish Trend 7 days ago
80%
Bullish Trend 13 days ago
56%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
61%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
61%
Aroon
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
52%
View a ticker or compare two or three
Ad is loading...
ADPT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CSLLY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYPAX52.21-0.07
-0.13%
Rydex Transportation H
VEUVX32.40-0.13
-0.40%
JPMorgan Europe Dynamic R6
USWGX31.58-0.33
-1.03%
Victory Sustainable World A
EACPX59.45-1.21
-1.99%
Eaton Vance Tax-Managed Multi-Cap Gr A
OPTIX100.43-2.14
-2.09%
Invesco Capital Appreciation R6

ADPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADPT has been loosely correlated with AXON. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ADPT jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADPT
1D Price
Change %
ADPT100%
-8.96%
AXON - ADPT
56%
Loosely correlated
-0.86%
TECH - ADPT
56%
Loosely correlated
-6.85%
VCYT - ADPT
54%
Loosely correlated
-2.97%
BEAM - ADPT
54%
Loosely correlated
-8.59%
ABCL - ADPT
53%
Loosely correlated
-3.99%
More

CSLLY and

Correlation & Price change

A.I.dvisor indicates that over the last year, CSLLY has been loosely correlated with EXAI. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if CSLLY jumps, then EXAI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSLLY
1D Price
Change %
CSLLY100%
-3.76%
EXAI - CSLLY
39%
Loosely correlated
-11.68%
ADPT - CSLLY
34%
Loosely correlated
-8.96%
RXRX - CSLLY
34%
Loosely correlated
-10.64%
VIR - CSLLY
33%
Poorly correlated
-7.29%
FOLD - CSLLY
33%
Poorly correlated
-4.06%
More